Human umbilical cord mesenchymal stem cell-derived exosomes suppress dermal fibroblasts-myofibroblats transition via inhibiting the TGF-β1/Smad 2/3 signaling pathway
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 115, 104468
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Myocardial fibroblast–matrix interactions and potential therapeutic targetsJournal of Molecular and Cellular Cardiology, 2014
- Exosomes Derived from Mesenchymal Stem CellsInternational Journal of Molecular Sciences, 2014
- Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: Role of secretome and exosomesBiochimie, 2013
- The complex dialogue between (myo)fibroblasts and the extracellular matrix during skin repair processes and ageingPathologie Biologie, 2012
- Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transitionJournal of Dermatological Science, 2012
- Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's - derived fibroblastsBMC Musculoskeletal Disorders, 2011
- Cancer Exosomes Trigger Fibroblast to Myofibroblast DifferentiationCancer Research, 2010
- Smad2 Protects against TGF-β/Smad3-Mediated Renal FibrosisJournal of the American Society of Nephrology, 2010
- The MyofibroblastThe American Journal of Pathology, 2007
- Common and unique mechanisms regulate fibrosis in various fibroproliferative diseasesJournal of Clinical Investigation, 2007